Current Report — Form 8-K Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 28K
7: EX-99.1 Miscellaneous Exhibit HTML 141K
9: R1 Document and Entity Information HTML 46K
11: XML IDEA XML File -- Filing Summary XML 12K
8: XML XBRL Instance -- hae-20201104_htm XML 21K
10: EXCEL IDEA Workbook of Financial Reports XLSX 6K
3: EX-101.CAL XBRL Calculations -- hae-20201104_cal XML 7K
4: EX-101.DEF XBRL Definitions -- hae-20201104_def XML 9K
5: EX-101.LAB XBRL Labels -- hae-20201104_lab XML 67K
6: EX-101.PRE XBRL Presentations -- hae-20201104_pre XML 33K
2: EX-101.SCH XBRL Schema -- hae-20201104 XSD 11K
12: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K
13: ZIP XBRL Zipped Folder -- 0000313143-20-000074-xbrl Zip 32K
(Address of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: i781-i848-7100
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
stock, $.01 par value per share
iHAE
iNew York Stock Exchange
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
i☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 4,
2020, Haemonetics Corporation issued a press release announcing financial results for the second quarter ended September 26, 2020 and first half of fiscal 2021. A copy of the release is furnished with this report as Exhibit 99.1.
The foregoing information, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
